- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02423850
Three-dimensional Measurements of Diabetic Foot Ulcers
Three-dimensional Measurements for Monitoring Wound Healing of Diabetic Foot Ulcers
Diabetic foot ulcers constitute an increasing health problem in Denmark concurrent with an ageing population and an increase in diabetes prevalence. Diabetic foot ulcers belong to the most serious and costly complications. Several studies have found that the size and depth of the ulcer is one of the major etiologic factors for delayed healing. Wound measurement is important in the monitoring of the wound healing process. For the last decade different 3D (three-dimensional) techniques for measuring wounds have been proposed in order to measure wound volume, but none of the technologies have been widely used. A 3D Wound Assessment Monitor (WAM) camera has been developed, which is able to measure wound size in 3D and to assess wound characteristics.
The investigators hypothesize that three-dimensional measurements of diabetic foot ulcers are feasible in the assessment of wound healing. A prospective cohort study is conducted in which newly admitted patients with a diabetic foot ulcer are included at the first visit at the multidisciplinary clinic. The patients are followed for one year or until complete wound healing, amputation or death. The four wound measurements: 2D area, 3D area, perimeter and volume are measured using the 3D-WAM camera with frequent intervals. Patient anthropometrics and wound data are collected during the study and correlated to the wound healing.
Aperçu de l'étude
Statut
Intervention / Traitement
Description détaillée
Method
Newly admitted patients with a diabetic foot ulcer are included at the first visit in the multidisciplinary clinic. The data mentioned below are collected at the first visit and the following examinations are performed including 3D photos. The wound size (2D area, 3D area, perimeter and volume) are estimated from the photos using the 3D-WAM camera. The wound examination is repeated after 2, 4, 8, 12, 24, 36 and 52 weeks or until healing of the wound. The wound healing is estimated using changes in wound size per time unit. Patients are treated by standard ulcer treatment methods and are unaffected by the project per se. During the trial the different methods of treatment are noted including changes from initial treatment. The variables will be quantified after one year depending on time to heal, establishment of a chronic ulcer (non-healing after one year) or an amputation has been performed.
At baseline the following patient data will be collected:
- Demographic data: gender, age
- Smoking habits
- Time period between onset of wound to first visit in the multidisciplinary clinic
- Body Mass Index
- Comorbidity using Charlson Comorbidity Index score
- Type of diabetes, duration of diabetes
- Diabetic complications including retinopathy, albuminuria, coronary heart diseases and neuropathy
The following examinations will be performed at baseline:
- Blood pressure measurement
- Peripheral blood pressure
- Examination for neuropathy using monofilament
- Blood samples from patients with a diabetic foot ulcer
The clinical examination of the ulcer are performed at baseline and after 2, 4, 8, 12, 24, 36 and 52 weeks or until wound healing:
- Size of wound (2D area, 3D area, perimeter, volume) measured using the 3D-WAM camera
- Size of wound in 2D area using the digital imaging method with the software ImageJ
- Location of the ulcer
- Classification of ulcer: granulation, necrosis, epithelialisation
- Secretory potential
- Foot deformity
- Bone affection - if osteitis is suspected an x-ray is taken
- Signs of infection
The different types of ulcer treatment is registered for every ulcer:
- Type of bandage
- Antibiotics (local, systemic)
- Revision (method, frequency),
- Surgery
Effect variables
- Wound 2D area, 3D area, perimeter and volume
- Variation in 2D and 3D area measurements during the study period
- Percentage change in wound size after 2, 4, 8, 12, 24, 36 and 52 weeks
Endpoints
- Wound healing
- Amputations
- Chronic wound (non-healing after 1 year)
- Death
Significance
This project seeks to clarify whether 3D photos of wounds will provide accurate structural measures to illuminate the background for delayed ulcer healing, and thereby to create platform for a more evidence based treatment algorithm.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Odense, Danemark, 5000
- University Centre of Wound Healing, Odense University Hospital (OUH)
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Newly admitted patients with diabetic foot ulcers
- 18 years or older
Exclusion Criteria:
- Superficial wound (less than 5x5 mm with no substantial loss of subcutaneous tissue)
- Non-compliance (dementia, mental disorders)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Diabetic foot ulcers
Newly referred patients with diabetic foot ulcers from the multidisciplinary clinic: University Centre for Wound healing, Odense University Hospital, Denmark.
|
Three-dimensional wound measurement (2D area, 3D area, perimeter, volume) using 3D-WAM camera
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Wound healing change quantified using the 3D-WAM camera
Délai: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
|
The 3D wound measurements at week 2, 4, 8, 12, 24, 36 and 52 are compared to the baseline measurement at week 0.
|
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
|
|
Wound healing change quantified using digital imaging method
Délai: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
|
The 2D wound measurements at week 2, 4, 8, 12, 24, 36 and 52 are compared to the baseline measurement at week 0.
|
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
The variability in 2D area and 3D area measurements
Délai: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
|
The variability in 2D area (digital imaging method) and 3D area wound measurements (3D-WAM camera) at week 0, 2, 4, 8, 12, 24, 36 and 52 are compared
|
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
|
|
Diabetes type is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
|
Type 1 and 2
|
Baseline until healing, amputation or chronic wound (52 weeks)
|
|
Diabetes duration is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
|
In years
|
Baseline until healing, amputation or chronic wound (52 weeks)
|
|
BMI (kg/m2) is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
|
kg/m2
|
Baseline until healing, amputation or chronic wound (52 weeks)
|
|
Charlson index score is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
|
In groups
|
Baseline until healing, amputation or chronic wound (52 weeks)
|
|
HbA1c is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
|
mmol/mol
|
Baseline until healing, amputation or chronic wound (52 weeks)
|
|
Ischemia is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
|
Ischemia is defined by ankle pressure below 70 mmHg and/or toe pressure below 45 mmHg
|
Baseline until healing, amputation or chronic wound (52 weeks)
|
|
Neuropathy is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
|
Neuropathy is measured by Semmes Weinstein monofilament examination
|
Baseline until healing, amputation or chronic wound (52 weeks)
|
|
Wound duration is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
|
In weeks
|
Baseline until healing, amputation or chronic wound (52 weeks)
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Quality of life (Questionaires) using 36-Item Short Form Survey (SF-36) is compared to outcome of the wound
Délai: Baseline, 24 and 52 weeks
|
The higher the score the less disability
|
Baseline, 24 and 52 weeks
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Knud Yderstræde, MD, PhD, Department of Endocrinology, Odense University Hospital
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Maladies cardiovasculaires
- Maladies vasculaires
- Troubles du métabolisme du glucose
- Maladies métaboliques
- Maladies de la peau
- Maladies du système immunitaire
- Maladies auto-immunes
- Maladies du système endocrinien
- Angiopathies diabétiques
- Ulcère de jambe
- Ulcère de la peau
- Neuropathies diabétiques
- Maladies du pied
- Diabète sucré
- Diabète sucré, Type 2
- Pied diabétique
- Ulcère du pied
- Diabète sucré, type 1
- Complications du diabète
Autres numéros d'identification d'étude
- OUH3D02
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Diabète sucré, Type 2
-
Instituto Nacional de Ciencias Medicas y Nutricion...Actif, ne recrute pas
-
Embecta Corp.Jaeb Center for Health ResearchRetiréDiabète de type 2 | Diabète sucré de type 2 (DT2) | DT2 (diabète sucré de type 2) | DT2 | DT2 | DM de type 2 | DT2 avec contrôle glycémique inadéquatÉtats-Unis
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... et autres collaborateursPas encore de recrutementDiabète de type 2 | Diabète sucré de type 2Turquie (Türkiye)
-
Endogenex, Inc.Pas encore de recrutementDiabète sucré, Type 2 | Diabète | Diabète sucré de type 2 | Diabète de type 2 | Diabète de type 2
-
Beijing HospitalRecrutementPatients diabétiques de type 2 | DT2 (diabète sucré de type 2) | DT2Chine
-
Kaiser PermanenteThe Permanente Medical GroupInscription sur invitationDiabète de type 2 | Diabète sucré de type 2 (DT2) | Diabète de type 2 (DT2)États-Unis
-
Endogenex, Inc.Pas encore de recrutementDiabète sucré, Type 2 | Diabète | Diabète de type 2 | Diabète sucré de type 2 (DT2) | Diabète de type 2
-
Medical University of GrazComplétéDiabète de type 2 | Diabète sucré de type 2 (DT2) | Diabète de type 2, nécessitant de l'insulineL'Autriche
-
Virginia Commonwealth UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecrutementDiabète de type 2États-Unis
-
Bnai Zion Medical CenterInconnue